We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

146 hedge funds and large institutions have $734M invested in Cogent Biosciences in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 63 increasing their positions, 37 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

70% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 37

56% more call options, than puts

Call options by funds: $1.76M | Put options by funds: $1.13M

34% more capital invested

Capital invested by funds: $547M → $734M (+$187M)

10% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 30

1% more funds holding

Funds holding: 144 → 146 (+2)

2.93% less ownership

Funds ownership: 108.08% → 105.14% (-2.9%)

Holders
146
Holders Change
+2
Holders Change %
+1.39%
% of All Funds
2.1%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
33
Increased
63
Reduced
37
Closed
30
Calls
$1.76M
Puts
$1.13M
Net Calls
+$632K
Net Calls Change
-$13K

Top Buyers

1
State Street
State Street
Massachusetts
+$21.5M
2
KCM
Kynam Capital Management
New Jersey
+$16.4M
3
SI
Sofinnova Investments
California
+$14.8M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$12.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.3M

Top Sellers

1
SCM
Suvretta Capital Management
New York
-$21M
2
Morgan Stanley
Morgan Stanley
New York
-$16.5M
3
EAM
Eventide Asset Management
Massachusetts
-$13.1M
4
FLSM
Frazier Life Sciences Management
California
-$6.54M
5
Citadel Advisors
Citadel Advisors
Florida
-$3.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Kynam Capital Management
New Jersey
$57.1M +$16.4M +2,645,234 +45%
State Street
2
State Street
Massachusetts
$51.3M +$21.5M +3,476,254 +84%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$46.8M +$10.3M +1,661,754 +31%
BlackRock
4
BlackRock
New York
$45M -$408K -65,966 -1%
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$44.9M +$9.18M +1,484,800 +29%
CC
6
Commodore Capital
New York
$43.2M +$5.31M +858,974 +15%
TCM
7
TCG Crossover Management
California
$41.8M +$3.61M +583,333 +10%
Vanguard Group
8
Vanguard Group
Pennsylvania
$38.7M +$7.61M +1,231,050 +27%
VA
9
VR Adviser
New York
$34.5M +$2.75M +445,000 +10%
FFM
10
Fairmount Funds Management
Pennsylvania
$31.8M +$7.21M +1,166,666 +33%
RG
11
Redmile Group
California
$26.6M +$6.48M +1,048,580 +36%
SI
12
Sofinnova Investments
California
$16.1M +$14.8M +2,400,771 New
Millennium Management
13
Millennium Management
New York
$15.8M -$2.73M -441,318 -16%
VC
14
Vivo Capital
California
$15.1M – – –
Janus Henderson Group
15
Janus Henderson Group
United Kingdom
$14.1M +$12.9M +2,083,065 +12,786%
Morgan Stanley
16
Morgan Stanley
New York
$12.4M -$16.5M -2,667,686 -59%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$11.9M +$299K +48,322 +3%
SVCM
18
Saturn V Capital Management
Texas
$10.7M +$5.18M +838,340 +111%
DM
19
Deerfield Management
New York
$10.3M +$2.75M +445,000 +41%
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$9.37M -$1.5M -242,636 -15%
Adage Capital Partners
21
Adage Capital Partners
Massachusetts
$8.96M +$8.24M +1,333,333 New
SCM
22
Silverarc Capital Management
Massachusetts
$6.97M +$432K +69,919 +7%
N
23
Nuveen
North Carolina
$6.87M +$4.81M +777,343 +318%
FLSM
24
Frazier Life Sciences Management
California
$6.29M -$6.54M -1,058,691 -53%
PA
25
Perceptive Advisors
New York
$5.94M -$1.48M -239,625 -21%
1
2 3 4 5

COGT Hedge Fund Activity: Q1 2024 in Review

146 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q1 2024, worth a combined $734M — up 34% from $547M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new COGT positions and 30 closed out — a net gain of 3 holders — while 63 added to existing stakes and 37 trimmed.

The largest buyer was State Street, adding an estimated $21.5M. The largest seller was Suvretta Capital Management, cutting an estimated $21M.

  • 146 institutional investors held Cogent Biosciences (COGT) as of Q1 2024, up from 144 in Q4 2023.
  • Funds reported $734M of Cogent Biosciences stock for Q1 2024, up 34% quarter-over-quarter.
  • 33 funds opened new Cogent Biosciences positions in Q1 2024 and 30 closed out, a net change of +3 holders.
  • The largest Cogent Biosciences buyer in Q1 2024 was State Street, an estimated $21.5M added.
  • The largest Cogent Biosciences seller in Q1 2024 was Suvretta Capital Management, an estimated $21M sold.

Based on aggregated 13F filings for Q1 2024.